Sort by
Keyphrases
Arginine
100%
Deprivation
100%
Prostate Cancer Cells
100%
Recombinant Human Arginase
100%
Ornithine Transcarbamylase Deficiency
40%
DU145
30%
Argininosuccinate Synthetase
30%
PC-3
30%
Arginine Deprivation
30%
In Cancer
20%
Cytotoxicity
20%
Gene Expression
20%
Cancer Cells
20%
LNCaP
20%
Mammalian Target of Rapamycin (mTOR)
20%
4E-BP1
20%
Androgen-independent
20%
Antiproliferative Activity
10%
Apoptosis Induction
10%
Quantitative PCR
10%
Cell Culture Media
10%
Phosphorylation
10%
Clinical Investigation
10%
Prostate Cancer
10%
Arginine Deiminase
10%
Prostate Cancer Cell Lines
10%
Ornithine
10%
Novel Agents
10%
Cell Death Pathways
10%
Downstream Effectors
10%
Cell Viability Assay
10%
Autophagy
10%
Preclinical Evaluation
10%
Half Maximal Inhibitory Concentration
10%
Melanoma Cancer
10%
Prostate Radiotherapy
10%
Human Prostate Cancer Cells
10%
Alternative Cell Death
10%
Medicine and Dentistry
Cancer Cell
100%
Arginase
100%
Prostate Cancer
100%
Arginine
100%
Ornithine Carbamoyltransferase
40%
Argininosuccinate Synthase
30%
Gene Expression
20%
Mechanistic Target of Rapamycin
20%
Cytotoxicity
20%
Androgen
20%
Autophagy
10%
Programmed Cell Death
10%
Malignant Neoplasm
10%
Antiproliferative Activity
10%
Arginine Deiminase
10%
Prostate Cancer Cell Line
10%
Cell Viability Assay
10%
Cancer Therapy
10%
Clinical Trial
10%
Real-Time Polymerase Chain Reaction
10%
Cell Death
10%
Cell Culture
10%
Ornithine
10%
Cell Line
10%
IC50
10%
Melanoma
10%
Immunology and Microbiology
Cancer Cell
100%
Arginine
100%
Sirolimus
40%
Cytotoxicity
40%
Gene Expression
40%
Real-Time Polymerase Chain Reaction
20%
IC50
20%
Prostate
20%
Cell Line
20%
Cell Culture
20%
Cell Death
20%
Antiproliferative Activity
20%
Cell Viability
20%
Prostate Cancer Cell Line
20%
Autophagy
20%
Arginine Deiminase
20%
Programmed Cell Death
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Arginase
100%
Arginine
100%
Ornithine Transcarbamylase
40%
Argininosuccinate Synthase
30%
LNCaP
20%
Gene Expression
20%
Cytotoxicity
20%
Mechanistic Target of Rapamycin
20%
Clinical Trial
10%
Cell Culture
10%
Real-Time Polymerase Chain Reaction
10%
Antiproliferative Activity
10%
IC50
10%
Cell Viability
10%
Autophagy
10%
Cell Death
10%
Arginine Deiminase
10%
Ornithine
10%
Programmed Cell Death
10%
Pharmacology, Toxicology and Pharmaceutical Science
Arginase
100%
Prostate Cancer
100%
Arginine
100%
Ornithine Carbamoyltransferase
40%
Malignant Neoplasm
30%
Argininosuccinate Synthase
30%
Androgen
20%
Mammalian Target of Rapamycin
20%
Cytotoxicity
20%
Antiproliferative Activity
10%
Cell Culture
10%
Clinical Trial
10%
Viability Assay
10%
Cell Viability
10%
Arginine Deiminase
10%
Melanoma
10%
IC50
10%
Ornithine
10%